Atypical Apocrine Adenosis of the Breast: Long-term Follow-up in 37 Patients
Authors:
- Lynn HartmannLHLynn Hartmann
- Amy DegnimADAmy Degnim
- Teresa AllersTATeresa Allers
- Robert VierkantRVRobert Vierkant
- Marlene FrostMFMarlene Frost
- Daniel VisscherDVDaniel Visscher
- 1 February 2012
- journal article
- Published by Archives of Pathology and Laboratory Medicine in Archives of Pathology & Laboratory Medicine
- Vol. 136 (2) , 179-182
Abstract
Context.—Atypical apocrine adenosis is a rare breast lesion in which the cellular population demonstrates cytologic alterations that may be confused with malignancy. The clinical significance and management of atypical apocrine adenosis are unclear because of the lack of long-term follow-up studies. Objective.—To determine the breast cancer risk in a retrospective series of patients with atypical apocrine adenosis diagnosed in otherwise benign, breast excisional biopsies. Design.—We identified 37 atypical apocrine adenosis cases in the Mayo Benign Breast Disease Cohort (9340 women) between 1967 and 1991 with a blinded pathology rereview. Breast cancer diagnoses subsequent to initial atypical apocrine adenosis biopsy were identified (average follow-up, 14 years). Results.—The mean age at diagnosis of atypical apocrine adenosis in the group was 59 years. Breast carcinoma subsequently developed in 3 women (8%) with atypical apocrine adenosis, diagnosed after follow-up intervals of 4, 12, and 18 years. The tumor from 1 of the 3 cases (33%) was ductal carcinoma in situ, contralateral to the original biopsy, and the other 2 cases (66%) were invasive carcinoma. Ages at the time of diagnosis of atypical apocrine adenosis were 55, 47, and 63 years for those that developed in situ or invasive carcinoma. Conclusions.—(1) Atypical apocrine adenosis was a rare lesion during the accrual era of our cohort (<1% of cases); (2) women found to have atypical apocrine adenosis were, on average, older than were other patients with benign breast disease, however, there does not seem to be an association with age and risk for developing carcinoma in patients diagnosed with atypical apocrine adenosis, as previously suggested; and (3) atypical apocrine adenosis does not appear to be an aggressive lesion and should not be regarded as a direct histologic precursor to breast carcinoma.Keywords
This publication has 10 references indexed in Scilit:
- Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case.Archives of Pathology & Laboratory Medicine, 2009
- Apocrine Ductal Carcinoma In Situ Involving a Sclerosing Lesion With Adenosis: Report of a CaseArchives of Pathology & Laboratory Medicine, 2009
- Non-operative breast pathology: apocrine lesionsJournal of Clinical Pathology, 2007
- Benign Breast Disease and the Risk of Breast CancerNew England Journal of Medicine, 2005
- The Spectrum of Apocrine Lesions of the BreastAdvances in Anatomic Pathology, 2004
- Apocrine ductal carcinoma in situ of the breast: Histologic classification and expression of biologic markersHuman Pathology, 2001
- The Histologic Spectrum of Apocrine Lesions of the BreastPathology Patterns Reviews, 2000
- Intraductal proliferations of the breast: A review of histologic criteria for atypical intraductal hyperplasia and ductal carcinoma in situ, including apocrine and papillary lesionsAnnals of Diagnostic Pathology, 1998
- Atypical apocrine adenosis of the breast: A clinicopathologic study of 37 patients with 8.7-year follow-upCancer, 1996
- Atypical apocrine metaplasia in sclerosing lesions of the breast: a study of 51 patients.1991